Stock Screener · Library
ORAMED PHARMACEUTICALS INC. financial statement history
Source-linked financial facts for ORAMED PHARMACEUTICALS INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 127999000 | USD | 2021-11-24 | 2021 / FY | us-gaap:Assets | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 177820000 | USD | 2023-03-06 | 2022 / FY | us-gaap:Assets | 10-K · 0001213900-23-017837 |
| As of 2022-12-31 | 161642000 | USD | 2024-03-06 | 2023 / FY | us-gaap:Assets | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 220551000 | USD | 2025-03-27 | 2024 / FY | us-gaap:Assets | 10-K · 0001013762-25-003450 |
| As of 2024-12-31 | 155278000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Assets | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 230864000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Assets | 10-K · 0001213900-26-034835 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 95337000 | USD | 2021-11-24 | 2021 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 147937000 | USD | 2023-03-06 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-23-017837 |
| As of 2022-12-31 | 157109000 | USD | 2024-03-06 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 162584000 | USD | 2025-03-27 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001013762-25-003450 |
| As of 2024-12-31 | 143221000 | USD | 2026-03-26 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 133271000 | USD | 2026-03-26 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-26-034835 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 77245000 | USD | 2021-11-24 | 2021 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 27456000 | USD | 2024-03-06 | 2023 / FY | us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 10-K · 0001213900-24-020485 |
| As of 2022-12-31 | 40464000 | USD | 2024-03-06 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 9055000 | USD | 2024-03-06 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-24-020485 |
| As of 2024-12-31 | 54420000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 45947000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-26-034835 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 397000 | USD | 2021-11-24 | 2021 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 388000 | USD | 2023-03-06 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-23-017837 |
| As of 2022-12-31 | 815000 | USD | 2024-03-06 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 873000 | USD | 2025-03-27 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001013762-25-003450 |
| As of 2024-12-31 | 698000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 586000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-26-034835 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 6679000 | USD | 2021-11-24 | 2021 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 7368000 | USD | 2023-03-06 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-23-017837 |
| As of 2022-12-31 | 5746000 | USD | 2024-03-06 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 53214000 | USD | 2025-03-27 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001013762-25-003450 |
| As of 2024-12-31 | 5685000 | USD | 2026-03-26 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 19086000 | USD | 2026-03-26 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-26-034835 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2022-12-31 | 25000 | USD | 2023-03-06 | 2022 / FY | us-gaap:LongTermDebt | 10-K · 0001213900-23-017837 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-08-31 | 115773000 | USD | 2021-11-24 | 2021 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-21-062009 |
| As of 2021-12-31 | 166453000 | USD | 2023-03-06 | 2022 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-23-017837 |
| As of 2022-12-31 | 151812000 | USD | 2024-03-06 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-24-020485 |
| As of 2023-12-31 | 163821000 | USD | 2025-03-27 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001013762-25-003450 |
| As of 2024-12-31 | 146265000 | USD | 2026-03-26 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-26-034835 |
| As of 2025-12-31 | 199744000 | USD | 2026-03-26 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-26-034835 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | 2703000 | USD | 2021-11-24 | 2021 / FY | us-gaap:Revenues | 10-K · 0001213900-21-062009 |
| 2022-01-01 to 2022-12-31 | 2703000 | USD | 2024-03-06 | 2023 / FY | us-gaap:Revenues | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | 1340000 | USD | 2025-03-27 | 2024 / FY | us-gaap:Revenues | 10-K · 0001013762-25-003450 |
| 2025-01-01 to 2025-12-31 | 2000000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Revenues | 10-K · 0001213900-26-034835 |
Cost of revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 1987000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CostOfRevenue | 10-K · 0001213900-26-034835 |
Gross profit
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2025-01-01 to 2025-12-31 | 13000 | USD | 2026-03-26 | 2025 / FY | us-gaap:GrossProfit | 10-K · 0001213900-26-034835 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | 20989000 | USD | 2021-11-24 | 2021 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-21-062009 |
| 2022-01-01 to 2022-12-31 | 27639000 | USD | 2024-03-06 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | 8971000 | USD | 2025-03-27 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | 6324000 | USD | 2026-03-26 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | 6381000 | USD | 2026-03-26 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-26-034835 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | -24223000 | USD | 2021-11-24 | 2021 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-21-062009 |
| 2022-01-01 to 2022-12-31 | -40598000 | USD | 2024-03-06 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | -15769000 | USD | 2025-03-27 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | -12781000 | USD | 2026-03-26 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | -15088000 | USD | 2026-03-26 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-26-034835 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | -22989000 | USD | 2021-11-24 | 2021 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-21-062009 |
| 2022-01-01 to 2022-12-31 | -36561000 | USD | 2024-03-06 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | 5088000 | USD | 2025-03-27 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | -19060000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | 64050000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-26-034835 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -0.94 | USD/shares | 2024-03-06 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | 0.14 | USD/shares | 2025-03-27 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | -0.48 | USD/shares | 2026-03-26 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | 1.5 | USD/shares | 2026-03-26 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-26-034835 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | -21181000 | USD | 2023-03-06 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-23-017837 |
| 2022-01-01 to 2022-12-31 | -27918000 | USD | 2024-03-06 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | -10295000 | USD | 2025-03-27 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | -8412000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | -9145000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-26-034835 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2020-09-01 to 2021-08-31 | 375000 | USD | 2023-03-06 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-23-017837 |
| 2022-01-01 to 2022-12-31 | 496000 | USD | 2024-03-06 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-24-020485 |
| 2023-01-01 to 2023-12-31 | 254000 | USD | 2025-03-27 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001013762-25-003450 |
| 2024-01-01 to 2024-12-31 | 18000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | 9000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-26-034835 |
Share repurchases
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2024-01-01 to 2024-12-31 | 2484000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0001213900-26-034835 |
| 2025-01-01 to 2025-12-31 | 4741000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PaymentsForRepurchaseOfCommonStock | 10-K · 0001213900-26-034835 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1176309
- Ticker in native snapshot
- ORMP
- Reported numeric facts
- 74
- Units present
- USD · USD/shares